Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-09

Clinical Trial Update: MAGNESIUM & SSRI VS SSRI ALONE AMONG PATIENTS OF MAJOR DEPRESSIVE DISORDER [Phase 2]

View source ↗

Summary

Phase 2 trial comparing magnesium augmentation to SSRI therapy versus SSRI alone in adults with major depressive disorder; the study is currently active but not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Magnesium (magnesium)
  • Selective serotonin reuptake inhibitor (selective serotonin reuptake inhibitor)

Snippet

Sponsor: University of Child Health Sciences and Children's Hospital, Lahore | Conditions: Major Depressive Diorder | Phase 2 | Status: ACTIVE_NOT_RECRUITING